AMGEN INC
$462.32
−3.35 (−0.72%) · delayed · Nov 16, 2026
Five-year price
52w $312.39 to $483.99
- Market cap
- $250.1B
- Enterprise value
- $295.5B
- P/E
- 32.5×
- 40.5× on 3y avg EPS
- EV / EBIT
- 32.5×
- FCF yield
- 3.2%
- ROIC
- 14.4%
- Debt / equity
- 6.31
- Piotroski F
- 7/9
Value scorecard · FY2025
Does it pass the value tests?
Quality
- ●ROIC > 12% (5y avg)5y avg ROIC 16.6%
- ●ROE > 15% (5y avg)5y avg ROE 106.7%
- ●Stable operating marginsMargin volatility 4.9% (σ, 5y)
- ●Earnings convert to cashFCF / net income 149% (5y avg)
- ●Growing revenueRevenue CAGR 5y 7.6%
- ●Shrinking share countDiluted shares -8.1% over 5y
Value
- ○P/E below 15P/E 32.5
- ○EV/EBIT below 12EV/EBIT 32.5
- ○FCF yield above 6%FCF yield 3.2%
- ○Price below Graham NumberGraham Number $71.59
- ○P/B below 3P/B 28.9
Safety
- ○Debt / equity below 0.5D/E 6.31
- ○Debt payable in < 4 yrs of earningsNet debt $45.5B
- –Interest coverage > 8xCoverage n/ax
- ○Current ratio > 1.5Current ratio 1.14
- ●Piotroski F-score ≥ 6F-score 7/9
Graham Defensive
- ●Adequate size (revenue > $2B)Revenue $36.8B
- ○Strong condition (current ratio ≥ 2)Current ratio 1.14
- ●Earnings stability (no loss, 10y)10 years of data
- ●Uninterrupted dividendsDividends paid every year on record
- ●Earnings growth ≥ 33% (10y, 3y avgs)EPS growth 34%
- ○Moderate P/E (≤ 15 on 3y avg EPS)P/E (3y avg) 40.5
- ○P/E × P/B ≤ 22.5Product 1168.6
Valuation lab
What do you have to believe?
At $462.32, the market is pricing in about 13.6% annual free-cash-flow growth for the next decade (9% discount rate, 2.5% terminal growth).
Starting cash flow
Net debt $45.5B · 541M shares · 5y revenue CAGR 7.6%
Intrinsic value
$273.67
Price
$462.32
Premium paid
69%
What the price implies
The market is paying for 13.6% annual cash-flow growth for 10 years at a 9.0% discount rate.
Terminal value share
60% of the value sits beyond year 10.
Financial statements
A decade of the record.
USD millions · fiscal years · source: SEC 10-K XBRL
| Line item | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 22,991 | 22,849 | 23,747 | 23,362 | 25,424 | 25,979 | 26,323 | 28,190 | 33,424 | 36,751 |
| Gross profit | — | — | — | — | — | — | — | — | — | — |
| Operating income | 9,794 | 9,973 | 10,263 | 9,674 | 9,139 | 7,639 | 9,566 | 7,897 | 7,258 | 9,080 |
| Operating margin | 42.6% | 43.6% | 43.2% | 41.4% | 35.9% | 29.4% | 36.3% | 28.0% | 21.7% | 24.7% |
| Pre-tax income | 9,163 | 9,597 | 9,545 | 9,138 | 8,133 | 6,701 | 7,346 | 7,855 | 4,609 | 8,976 |
| Income tax | 1,441 | 7,618 | 1,151 | 1,296 | 869 | 808 | 794 | 1,138 | 519 | 1,265 |
| Net income | 7,722 | 1,979 | 8,394 | 7,842 | 7,264 | 5,893 | 6,552 | 6,717 | 4,090 | 7,711 |
| EPS (diluted) | 10.24 | 2.69 | 12.62 | 12.88 | 12.31 | 10.28 | 12.11 | 12.49 | 7.56 | 14.23 |
| Diluted shares | 754 | 735 | 665 | 609 | 590 | 573 | 541 | 538 | 541 | 542 |
Who owns it